日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Study finds virus antibodies last at least 12 months

By WANG XIAOYU | CHINA DAILY | Updated: 2021-07-08 09:27
Share
Share - WeChat
A recovering pneumonia patient gives a thumbs-up to medical workers at Wuhan University's Zhongnan Hospital, in early 2020. [GAO XIANG/FOR CHINA DAILY]

Antibodies against the novel coronavirus can last for at least 12 months in more than 70 percent of recovered COVID-19 patients, a study published by Chinese researchers on Tuesday shows.

The finding adds to growing evidence that vaccination, which elicits an immune response in a way similar to how a live virus triggers human bodies to generate antibodies, can "effectively restrict the spread of SARS-CoV-2", the study said.

The study, published online by Nature Communications, was conducted by China National Biotech Group, a Sinopharm subsidiary, and the National Research Center for Translational Medicine at Shanghai Jiao Tong University.

Researchers collected 1,782 convalescent plasma samples from 869 recovered COVID-19 patients in Wuhan, Hubei province, within 12 months of diagnosis, and tested them for the presence and amount of RBDIgG, a type of antibody that indicates the strength of immunity against the virus.

Testing results showed that in nine months, levels of the antibody dropped to 64.3 percent of the initial level when they contracted the virus, and then stabilized into the 12th month.

"It shows that once immune responses against the novel coronavirus are induced in human bodies, antibody levels can be maintained for quite a long time," China National Biotech Group said in an article on its WeChat account on Wednesday.

The study found that the antibody response was significantly stronger in male participants than in their female counterparts in the early stages of infection, but the difference dwindled over time and nearly disappeared in 12 months.

Among participants aged 18 to 55, the older ones developed higher antibody levels, it added.

The company said the study is the longest-running research aimed at examining the persistence of antibody response in recovered COVID-19 patients.

The finding was published as mass vaccination in China proceeds smoothly, with the country stepping up vaccine donations or sales overseas.

As of Tuesday, about 1.3 billion doses of vaccines had been administered nationwide, the National Health Commission said on Wednesday.

China National Biotech Group added that the study will help improve understanding of the immunological memory elicited by the virus, and provide guidance on future research into vaccine-induced immunity and future vaccination policies in China and abroad.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 草草在线免费视频 | 久操视屏 | 日本在线观看视频网站 | 亚洲影院一区 | 亚洲午夜成激人情在线影院 | 侮辱丰满美丽的人妻 | 99影视 | 国产高清无专砖区2021 | 午夜网 | 黄色午夜电影 | 91se在线看片国产免费观看 | 一级色毛片| 日韩欧美精品在线 | 午夜在线视频一区二区三区 | 99久久产在线 | 日日摸日日添夜夜爽97 | 久久免费看 | 九九爱国产| 精品久久综合一区二区 | 好吊色欧美一区二区三区四区 | 女女女女bbbbbb毛片在线 | 国产一区二区欧美 | 另类视频综合 | 国产精品视频网站 | 国产精品美女久久久久久免费 | 日韩加勒比在线 | 九九在线精品视频播放 | 日韩美女一区二区三区在线观看 | 欧美三级三级三级爽爽爽 | 国产亚洲欧洲国产综合一区 | 凹凸日日摸日日碰夜夜爽孕妇 | 五月婷婷狠狠爱 | japanese末成年free | 日韩99 | 日韩一二三区 | 日本高清一区二区三区不卡免费 | 国产激情在线观看 | 亚洲 精品 综合 精品 自拍 | 小宝与康熙粤语 | 免费a级毛片 | 欧美影院推理片免费看 |